nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapiprazole—Risperidone—HRH1—atherosclerosis	0.0809	1	CrCbGaD
Dapiprazole—ADRA1B—Signaling by GPCR—EDNRA—atherosclerosis	0.000807	0.000878	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCR2—atherosclerosis	0.000807	0.000878	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000804	0.000875	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CX3CR1—atherosclerosis	0.000794	0.000864	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CASR—atherosclerosis	0.000794	0.000864	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCL3—atherosclerosis	0.000792	0.000862	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CCR2—atherosclerosis	0.000789	0.000859	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000789	0.000859	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—GHRL—atherosclerosis	0.000786	0.000855	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CX3CL1—atherosclerosis	0.000779	0.000847	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CCL2—atherosclerosis	0.000775	0.000843	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—F2—atherosclerosis	0.000772	0.00084	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—EDN1—atherosclerosis	0.000772	0.000839	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL4—atherosclerosis	0.000771	0.000839	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—GHRL—atherosclerosis	0.000769	0.000837	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CCL5—atherosclerosis	0.000766	0.000833	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—KNG1—atherosclerosis	0.00076	0.000827	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AGTR1—atherosclerosis	0.000755	0.000822	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOA4—atherosclerosis	0.000744	0.000809	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000741	0.000806	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CNR2—atherosclerosis	0.000738	0.000803	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CXCL8—atherosclerosis	0.000738	0.000803	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—MMP3—atherosclerosis	0.000737	0.000801	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000735	0.0008	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—PRKCG—atherosclerosis	0.000728	0.000792	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOA2—atherosclerosis	0.000721	0.000784	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCR2—atherosclerosis	0.000717	0.00078	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—EDNRA—atherosclerosis	0.000717	0.00078	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000714	0.000777	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—EDN1—atherosclerosis	0.000701	0.000762	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—GHRL—atherosclerosis	0.000698	0.00076	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CCL5—atherosclerosis	0.000695	0.000756	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—KNG1—atherosclerosis	0.00069	0.000751	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CCL2—atherosclerosis	0.000688	0.000749	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—UTS2—atherosclerosis	0.000688	0.000748	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AGTR1—atherosclerosis	0.000686	0.000746	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL4—atherosclerosis	0.000685	0.000746	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—KNG1—atherosclerosis	0.000675	0.000734	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000671	0.00073	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—PRKCG—atherosclerosis	0.000661	0.000719	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CX3CR1—atherosclerosis	0.000659	0.000717	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CASR—atherosclerosis	0.000659	0.000717	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—VWF—atherosclerosis	0.000658	0.000716	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOC3—atherosclerosis	0.000654	0.000712	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—LDLR—atherosclerosis	0.00065	0.000707	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CX3CL1—atherosclerosis	0.000646	0.000703	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—AGT—atherosclerosis	0.00064	0.000697	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—EDN1—atherosclerosis	0.00064	0.000697	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOA2—atherosclerosis	0.00064	0.000697	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CCL5—atherosclerosis	0.000635	0.000691	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCL3—atherosclerosis	0.000635	0.000691	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—KNG1—atherosclerosis	0.000613	0.000667	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CNR2—atherosclerosis	0.000613	0.000667	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CXCL8—atherosclerosis	0.000612	0.000666	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—MMP3—atherosclerosis	0.000611	0.000665	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—UTS2—atherosclerosis	0.000611	0.000664	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.00061	0.000664	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AGTR1—atherosclerosis	0.000609	0.000663	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NCF1—atherosclerosis	0.000608	0.000662	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—PRKCG—atherosclerosis	0.000604	0.000657	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—F2—atherosclerosis	0.000592	0.000644	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CASR—atherosclerosis	0.000585	0.000637	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CX3CR1—atherosclerosis	0.000585	0.000637	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AGT—atherosclerosis	0.000582	0.000633	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—EDN1—atherosclerosis	0.000582	0.000633	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCL5—atherosclerosis	0.000577	0.000628	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—EDNRA—atherosclerosis	0.000574	0.000625	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCR2—atherosclerosis	0.000574	0.000625	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CX3CL1—atherosclerosis	0.000574	0.000625	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CYBA—atherosclerosis	0.000572	0.000622	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—EDN1—atherosclerosis	0.000569	0.000619	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000566	0.000616	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CCL5—atherosclerosis	0.000564	0.000614	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PARP1—atherosclerosis	0.00056	0.000609	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PLAT—atherosclerosis	0.00056	0.000609	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—GHRL—atherosclerosis	0.00056	0.000609	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PRKCG—atherosclerosis	0.000549	0.000597	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—VWF—atherosclerosis	0.000546	0.000594	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	0.000544	0.000592	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	0.000544	0.000592	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	0.000543	0.000591	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOC3—atherosclerosis	0.000543	0.000591	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000542	0.00059	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—LDLR—atherosclerosis	0.00054	0.000587	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—F2—atherosclerosis	0.000537	0.000585	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000537	0.000584	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AGT—atherosclerosis	0.000532	0.000578	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL3—atherosclerosis	0.000527	0.000573	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	0.000517	0.000562	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—PIK3CG—atherosclerosis	0.000514	0.00056	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	0.000513	0.000558	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NCF1—atherosclerosis	0.000505	0.000549	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—F2—atherosclerosis	0.000491	0.000534	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—KNG1—atherosclerosis	0.000491	0.000534	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AGTR1—atherosclerosis	0.000488	0.000531	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	0.000487	0.00053	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—VWF—atherosclerosis	0.000485	0.000528	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AGT—atherosclerosis	0.000483	0.000525	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	0.000482	0.000525	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	0.000479	0.000521	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CCL2—atherosclerosis	0.000479	0.000521	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—EDNRA—atherosclerosis	0.000477	0.000519	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCR2—atherosclerosis	0.000477	0.000519	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PLG—atherosclerosis	0.000476	0.000518	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CYBA—atherosclerosis	0.000474	0.000516	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	0.000472	0.000514	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00047	0.000511	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	0.000468	0.000509	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PLAT—atherosclerosis	0.000464	0.000505	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PARP1—atherosclerosis	0.000464	0.000505	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—GHRL—atherosclerosis	0.000464	0.000505	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SOCS3—atherosclerosis	0.000451	0.00049	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	0.000448	0.000488	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—F2—atherosclerosis	0.000446	0.000485	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	0.000436	0.000475	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MMP3—atherosclerosis	0.000435	0.000473	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IGF2—atherosclerosis	0.000433	0.000471	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	0.000429	0.000467	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PIK3CG—atherosclerosis	0.000427	0.000464	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	0.000423	0.000461	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	0.000423	0.000461	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	0.000421	0.000459	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOB—atherosclerosis	0.000421	0.000458	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000417	0.000454	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCL8—atherosclerosis	0.000417	0.000454	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—EDN1—atherosclerosis	0.000414	0.00045	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	0.000413	0.000449	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	0.000413	0.000449	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	0.000413	0.000449	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCL5—atherosclerosis	0.000411	0.000447	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—KNG1—atherosclerosis	0.000408	0.000444	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AGTR1—atherosclerosis	0.000405	0.000441	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—LPL—atherosclerosis	0.000402	0.000437	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCL2—atherosclerosis	0.000398	0.000433	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—F2—atherosclerosis	0.000396	0.000431	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PLG—atherosclerosis	0.000395	0.00043	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PRKCG—atherosclerosis	0.00039	0.000425	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SPP1—atherosclerosis	0.00038	0.000414	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000379	0.000413	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCL8—atherosclerosis	0.000379	0.000412	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SOCS3—atherosclerosis	0.000374	0.000407	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	0.000362	0.000394	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	0.000361	0.000393	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	0.00036	0.000392	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	0.00036	0.000391	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	0.000353	0.000384	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PDGFB—atherosclerosis	0.000352	0.000383	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PLG—atherosclerosis	0.000351	0.000382	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOB—atherosclerosis	0.000349	0.00038	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	0.000346	0.000377	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AGT—atherosclerosis	0.000344	0.000374	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	0.000344	0.000374	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	0.000341	0.000371	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—LEP—atherosclerosis	0.000337	0.000366	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOE—atherosclerosis	0.000337	0.000366	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CAV1—atherosclerosis	0.000334	0.000363	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—LPL—atherosclerosis	0.000333	0.000363	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOA1—atherosclerosis	0.000333	0.000362	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	0.000332	0.000361	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	0.000324	0.000353	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ESR1—atherosclerosis	0.000321	0.00035	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	0.000321	0.000349	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	0.000319	0.000348	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—F2—atherosclerosis	0.000317	0.000345	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	0.000316	0.000343	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	0.000314	0.000342	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOB—atherosclerosis	0.00031	0.000337	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000307	0.000334	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	0.000305	0.000332	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PIK3CG—atherosclerosis	0.000304	0.000331	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	0.000303	0.000329	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—LPL—atherosclerosis	0.000296	0.000322	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	0.000292	0.000318	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—MAPK3—atherosclerosis	0.000291	0.000317	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	0.000288	0.000313	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—INS—atherosclerosis	0.000288	0.000313	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AGT—atherosclerosis	0.000285	0.00031	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCL2—atherosclerosis	0.000283	0.000308	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	0.00028	0.000305	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—LEP—atherosclerosis	0.000279	0.000304	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOE—atherosclerosis	0.000279	0.000304	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	0.000279	0.000304	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IGF1—atherosclerosis	0.000278	0.000303	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	0.000277	0.000301	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	0.000276	0.000301	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	0.000267	0.00029	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	0.000264	0.000287	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—F2—atherosclerosis	0.000263	0.000287	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	0.000259	0.000282	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AGT—atherosclerosis	0.000253	0.000276	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	0.000252	0.000274	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	0.000252	0.000274	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—LEP—atherosclerosis	0.000248	0.00027	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOE—atherosclerosis	0.000248	0.00027	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	0.000246	0.000268	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	0.000245	0.000267	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	0.000241	0.000263	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—INS—atherosclerosis	0.000239	0.00026	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	0.000237	0.000258	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	0.000235	0.000256	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—F2—atherosclerosis	0.000234	0.000255	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	0.000231	0.000251	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	0.000224	0.000244	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	0.000224	0.000243	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	0.000219	0.000239	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	0.000216	0.000235	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	0.000214	0.000233	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	0.000213	0.000231	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—INS—atherosclerosis	0.000212	0.000231	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	0.000209	0.000228	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	0.000209	0.000227	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	0.000205	0.000223	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	0.000202	0.00022	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	0.0002	0.000218	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	0.000197	0.000214	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	0.000196	0.000214	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	0.000195	0.000212	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	0.000186	0.000202	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	0.000186	0.000202	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	0.000182	0.000198	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	0.00018	0.000196	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	0.000179	0.000195	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	0.000177	0.000192	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	0.000172	0.000187	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	0.000168	0.000183	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	0.000167	0.000181	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	0.000166	0.000181	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	0.000165	0.000179	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	0.000163	0.000178	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	0.000163	0.000177	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	0.000159	0.000173	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	0.000157	0.000171	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	0.000151	0.000164	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	0.000149	0.000162	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	0.000149	0.000162	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	0.000148	0.000161	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	0.000145	0.000158	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	0.000145	0.000157	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	0.000143	0.000155	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	0.000138	0.000151	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	0.000134	0.000146	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	0.000133	0.000144	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	0.000127	0.000138	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL6—atherosclerosis	0.000126	0.000137	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	0.000123	0.000134	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	0.000116	0.000126	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL6—atherosclerosis	0.000104	0.000113	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	9.62e-05	0.000105	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL6—atherosclerosis	9.26e-05	0.000101	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	8.55e-05	9.3e-05	CbGpPWpGaD
